Biogaia AB OMXSTO:BIOG_B:
BIOGAIA AB EXTENDS LONG-STANDING DISTRIBUTION PARTNERSHIP WITH EWOPHARMA
BioGaia Extends Distribution Partnership With Ewopharma
Watch BioGaia's latest callBiogaia (Stockholm:BIOG B) Q2 2026 Earnings Call · Replay · Jul 17Read the transcript of Biogaia (Stockholm:BIOG B) Q2 2026 Earnings CallEarlier from BioGaia
- BIOG_B: Q4 organic sales up 32%, EBIT margin 27%, and direct markets now 40% of sales
- BioGaia's prelim Q4 sales rise 21%, margins expand
- BIOG_B: Sales up 7%, EBIT margin 26%, direct markets and innovation drive future growth
- BioGaia AB: Quarterly Trading Report 2025 Q3
- BIOG_B: Q2 saw 5% sales growth and direct channel expansion, but EBIT dropped 20% on higher OpEx
Later from BioGaia
- BioGaia Exercises Option To Acquire Remaining Shares In Nutraceutics
- Biogaia Research Confirms Effectiveness Longevityguard Technology
- BIOG_B: 15% organic growth and robust new product launches fueled strong Q1 results, despite FX headwinds
Follow BioGaia into a list and get an email when it puts out news.
Follow BioGaia